BRISTOL MYERS SQUIBB FDA Approval NDA 020286

NDA 020286

BRISTOL MYERS SQUIBB

FDA Drug Application

Application #020286

Documents

Letter2009-02-13
Letter2003-11-05

Application Sponsors

NDA 020286BRISTOL MYERS SQUIBB

Marketing Status

Discontinued001
Discontinued002

Application Products

001TABLET;ORAL20MG;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1MONOPRIL-HCTFOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE
002TABLET;ORAL10MG;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1MONOPRIL-HCTFOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE

FDA Submissions

TYPE 4; Type 4 - New CombinationORIG1AP1994-11-30STANDARD
LABELING; LabelingSUPPL2AP1996-07-24STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1997-05-20STANDARD
LABELING; LabelingSUPPL4AP2001-02-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL5AP2000-03-24STANDARD
LABELING; LabelingSUPPL6AP2003-10-29STANDARD
LABELING; LabelingSUPPL8AP2009-02-09STANDARD

Submissions Property Types

ORIG1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL8Null0

CDER Filings

BRISTOL MYERS SQUIBB
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20286
            [companyName] => BRISTOL MYERS SQUIBB
            [docInserts] => ["",""]
            [products] => [{"drugName":"MONOPRIL-HCT","activeIngredients":"FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE","strength":"20MG;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"MONOPRIL-HCT","activeIngredients":"FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE","strength":"10MG;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"MONOPRIL-HCT","submission":"FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE","actionType":"20MG;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"MONOPRIL-HCT","submission":"FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE","actionType":"10MG;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.